Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (161-170 of 337) with videos related to

Pageof 34
Sort By:
Therapeutic Drug Monitoring|July 27, 2019
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human PlasmaErik van den Hombergh, Nikki de Rouw, Michel van den Heuvel, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2004
Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected childrenAlina S Bergshoeff, Pieter L A Fraaij, Corrien Verweij, et al.
The Pediatric Infectious Disease Journal|May 30, 2006
Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected childrenMarthe LePrevost, Hannah Green, Jacquie Flynn, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2026
Mapping drug-drug interactions in pharmacokinetic boosting of olaparibJoanneke K Overbeek, Sarmad M S Naoom, Laura Nijboer, et al.
Therapeutic Drug Monitoring|July 22, 2008
Therapeutic drug monitoring of voriconazoleRoger J M Brüggemann, J Peter Donnelly, Rob E Aarnoutse, et al.
AIDS (London, England)|December 22, 2021
Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity?Indy G Murdoch, Tom G Jacobs, Rosa M Nieuwenhuize, et al.
Clinical Pharmacokinetics|February 5, 2025
Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug OlaparibJoanneke K Overbeek, Nielka P van Erp, David M Burger, et al.
Clinical Pharmacokinetics|April 4, 2022
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill PatientsEveline Wallenburg, Rob Ter Heine, Jeroen A Schouten, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 20, 2011
Pediatric underdosing of efavirenz: a pharmacokinetic study in UgandaQuirine Fillekes, Eva Natukunda, Jackie Balungi, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2010
Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteersRoger J M Brüggemann, Matthijs van Luin, Engelina P H Colbers, et al.
Pageof 34

Showing results (161-170 of 337) with videos related to

Sort By:
Pageof 34
Therapeutic Drug Monitoring|July 27, 2019
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human PlasmaErik van den Hombergh, Nikki de Rouw, Michel van den Heuvel, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2004
Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected childrenAlina S Bergshoeff, Pieter L A Fraaij, Corrien Verweij, et al.
The Pediatric Infectious Disease Journal|May 30, 2006
Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected childrenMarthe LePrevost, Hannah Green, Jacquie Flynn, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2026
Mapping drug-drug interactions in pharmacokinetic boosting of olaparibJoanneke K Overbeek, Sarmad M S Naoom, Laura Nijboer, et al.
Therapeutic Drug Monitoring|July 22, 2008
Therapeutic drug monitoring of voriconazoleRoger J M Brüggemann, J Peter Donnelly, Rob E Aarnoutse, et al.
AIDS (London, England)|December 22, 2021
Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity?Indy G Murdoch, Tom G Jacobs, Rosa M Nieuwenhuize, et al.
Clinical Pharmacokinetics|February 5, 2025
Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug OlaparibJoanneke K Overbeek, Nielka P van Erp, David M Burger, et al.
Clinical Pharmacokinetics|April 4, 2022
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill PatientsEveline Wallenburg, Rob Ter Heine, Jeroen A Schouten, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 20, 2011
Pediatric underdosing of efavirenz: a pharmacokinetic study in UgandaQuirine Fillekes, Eva Natukunda, Jackie Balungi, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2010
Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteersRoger J M Brüggemann, Matthijs van Luin, Engelina P H Colbers, et al.
Pageof 34